Evidence map›Paper›PMID 19036981›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Modeling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions.

Juraj Kukolja, Thomas E Schläpfer, Christian Keysers, Dietrich Klingmüller, Wolfgang Maier, Gereon R Fink, René Hurlemann

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Acute stress induces selective alterations in cost/benefit decision-making.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juraj KukoljaCognitive Neurology Section, Institute of Neuroscience and Biophysics-Medicine, Research Centre Juelich, 52425 Juelich, Germany. juraj.kukolja@uk-koeln.de
Thomas E Schläpfer
Christian Keysers
Dietrich Klingmüller
Wolfgang Maier
Gereon R Fink
René Hurlemann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An emerging theme in the neuroscience of emotion is the question of how acute stress shapes, and distorts, social-emotional behavior. The prevailing neurocircuitry models of social-emotional behavior emphasize the central role of the amygdala. Acute stress leads to increased central levels of norepinephrine (NE) and cortisol (CORT), and evidence suggests that these endogenous neuromodulators synergistically influence amygdala responses to social-emotional stimuli. We therefore hypothesized that amygdala responses to emotional facial expressions would be susceptible to pharmacologically induced increases in central NE and CORT levels. To specifically test this hypothesis, we measured amygdala activation to emotional faces using functional magnetic resonance imaging in 62 healthy subjects under four pharmacological conditions: (1) single oral dose of placebo, (2) 4 mg of the selective NE-reuptake inhibitor reboxetine (RBX), (3) 30 mg of hydrocortisone, or (4) both drugs in combination. We found that a decrease in amygdala activation to positive facial emotion was coupled with an increase in amygdala activation to negative facial emotion in the RBX-CORT combined challenge condition. In conclusion, a pharmacologically induced elevation of central NE and CORT levels in healthy subjects created a negative response bias in the amygdala that did not exist at baseline. Our results implicate a causative role of NE-CORT interactions in the emergence of a negative bias of cognitive and emotional functions which is germane in stress-related affective spectrum disorders.

Indexed as

Adrenergic Uptake InhibitorsAdultAmygdalaBiasBrain MappingEmotionsFacial ExpressionFemaleGlucocorticoidsHumansMagnetic Resonance ImagingMaleMood DisordersMorpholinesNeuropsychological TestsNorepinephrineAdrenergic Uptake InhibitorsGlucocorticoidsMorpholinesNorepinephrineReboxetine

Identifiers

PMID19036981
PMCPMC6671813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.